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MMPs and TIMPs expression in facial tissue of children with cleft lip and palate
Liene Smane-Filipovaa, Mara Pilmanea, Ilze Akotab
Background and Aims. Morphogenesis of the upper lip and palate is a complex process involving highly regulated in-
teractions between epithelial and mesenchymal cells. Genetic evidence in humans and mice indicates the involvement 
of matrix metalloproteinases (MMPs) and their endogenous tissue inhibitors (TIMPs) in cleft lip palate (CLP) aetiology. 
This study investigated whether expression of MMP-2, MMP-8, MMP-9, TIMP-2, and TIMP-4, which are essential for the 
upper lip and palate fusion, is dysregulated in children with CLP.
Methods. Oral mucosa tissue samples were obtained from patients with complete unilateral (CU) CLP (n = 25) and 
complete bilateral (CB) CLP (n = 19) during corrective plastic surgery and in unaffected control subjects (n = 10). MMPs 
and TIMPs expression was assessed by immunohistochemistry, and the data were analyzed using the Kruskal – Wallis 
test with the Bonferroni correction.
Results. In CLP patients, MMP-2, TIMP-2 immunoreactivity in the oral mucosa was seen to have a few to abundant 
structures, but the overall number of MMP-2, TIMP-2-positive structures was greater than that in controls (P < 0.01). 
The total number of TIMP-4, MMP-9-positive cells showed a significant decrease in the CBCLP compared with that of 
CUCLP (P < 0.001). MMP-8 expression trends in the CLP group were similar to those of the control group.
Conclusions. The results suggest that TIMP-4 and MMP-9 are the main ECM remodeling regulatory proteins expressed 
in CUCLP affected tissues of the oral mucosa. The increased expression of MMP-2 and TIMP-2 in CLP tissues impli-
cates these factors in the regulation of cell migration during ECM turnover independently of different types of clefts. 
Investigation of MMP and TIMP expression in tissue samples from patients with CLP appears to be a promising ap-
proach to the etiopathogenesis of CLP.
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INTRODUCTION
Craniofacial anomalies, in particular cleft lip and pal-
ate (CLP), are the most prevalent birth defects in humans 
with a worldwide frequency of 1 in 500 to 1000 livebirths1. 
About 70% of cases are considered non-syndromic CLP 
(NSCLP), whereas the remaining approximately 30% of 
CLP are syndromic2. Clinically, cleft lip and palate is a 
unilateral or bilateral gap between the philtrum and the 
lateral upper lip. 
The etiology of this pathology has only been partially 
explained to date. In both humans and mice, it is known 
that environmental and epigenetic factors affect NSCLP 
susceptibility3. However, in most non-syndromic cases, 
the cause remains unknown. CLP is characterized by the 
incomplete fusion of the lip, alveolus, and hard and soft 
palates, with the most severe clefts extending completely 
through both soft tissue and bone. The mechanisms for 
explaining the incomplete fusion of the facial structures 
are complex and not fully understood. Three main mecha-
nisms have been proposed: programmed cell death4, cell 
migration to the oral and nasal side of the palate5, and 
epithelial-mesenchymal transdifferentiation6. Normal de-
velopment of the lip and palate involves a series of highly 
coordinated morphogenetic events that include cell migra-
tion, differentiation, growth, apoptosis, active fusion, and 
subsequent breakdown of the medial edge epithelium, as 
well as breakdown of the basement membrane. Any dis-
turbance in these events may cause irreversible changes 
resulting in the development of facial clefts.
Some proteases, such as matrix metalloproteinases 
(MMPs), are responsible for remodeling of the extracel-
lular matrix (ECM) and mediate changes in the base-
ment membrane components of the medial edge seam 
during lip and palate fusion and their imbalance can lead 
to CLP (ref.7). Several studies demonstrate that tissue 
remodeling by MMPs plays an important role in the late 
stages of lip and palate formation. Together with their 
endogenous tissue inhibitors (TIMPs) MMPs are gener-
ally rarely expressed in healthy tissues. Their expression 
increases during physiological or pathological tissue re-
modeling with the influence of signaling molecules able 
to modulate gene expression8. MMPs and TIMPs have 
been suggested to be candidate genes based on research 
of their spatial and temporal expression patterns during 
palatogenesis in animals9.
Thus, the process of CLP morphogenesis is closely 
accompanied by changes in the composition of the ex-
tracellular matrix that promote cell migration and dif-
ferentiation, cell-cell interactions, and tissue resorption. 
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This study investigated the expression of MMP-2, MMP-
8, MMP-9, TIMP-2, and TIMP-4 in complete unilateral 
(CU), complete bilateral (CB) CLP to identify possible 
changes in signaling pathways that could lead to the ab-
berant maxillofacial morphogenesis observed in CLP.
MATERIALS AND METHODS
Study population
The study was carried out according to the Declaration 
of Helsinki, and the protocal was independently reviewed 
and approved by the local Ethics Committee of  Riga 
Stradins University. Written informed consent was ob-
tained from all parents after the nature of the study had 
been fully explained.
Samples for the study were retrieved from the Cleft 
Lip and Palate Centre of the Institute of Stomatology of 
the Riga Stradins University. Forty-four CLP patients were 
enrolled. Twenty-five children had unilateral CLP, while 
19 children had bilateral CLP. There were 19 boys and 
6 girls in the unilateral CLP patients and 14 males and 
5 females in the bilateral CLP patients. 
In our study the tissue samples are not from the foetal 
period where the development of the lip and palate takes 
place but from fully development children aged (3 months 
and 8 years and 5 months). To attain optimal healing and 
hence cosmetic and functional results, a small piece of 
mucosa is routinely removed during the operation from 
borders of the cleft region. Patient samples were obtained 
during various surgeries, such as labioplasty, veloplasty 
and uranoplasty. Samples of oral mucosa were collected 
in upper labial frenectomy from control subjects ranging 
in age from 5 years to 7 years.
Tissue sample preparation
For conventional light microscopy and immunohis-
tochemistry, tissue samples were fixed for one day in 
Stefanini’s fixative for 24 h. After fixation, tissue blocks 
were embedded in paraffin. Three-micrometer thick sec-
tions were cut from each block, affixed onto the glass 
slides, then de-paraffinized in xylene, rehydrated through 
graded alcohol solutions and stained with hematoxylin-
eosin.
Immunohistochemistry
Three-micrometer thick sections were cut from the 
same blocks and placed on adhesive microscope slides 
with silane treated surfaces for immunohistochemical 
analysis. Tissue sections were labeled with the follow-
ing primary antibodies: mouse anti-MMP-2 at 1:100 (sc-
53630; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, 
USA), mouse anti-TIMP-2 at 1:100 (sc-21735; Santa Cruz 
Biotechnology, Inc., Santa Cruz, CA, USA), rabbit anti-
MMP-9 at 1:100 (sc-10737; Santa Cruz Biotechnology, 
Inc., Santa Cruz, CA, USA), and rabbit anti-TIMP-4 at 
1:100 (sc-30076; Santa Cruz Biotechnology, Inc., Santa 
Cruz, CA, USA). The slides were processed as follows: 
de-paraffinization; rehydrated through graded alcohol 
solutions; endogenous peroxidase activity was blocked 
by incubation with kit peroxidase blocking reagent for 10 
minutes; the antibodies were diluted with the Antibody 
Diluent (64211; Abcam, Burlingame, CA, USA); HiDef 
DetectionTM Amplifier (Mouse & Rabbit) (954D-31; 
Sigma-Aldrich, Rocklin, CA, USA) was applied for 10 
minutes; HiDef DetectionTM  HRP Polymer Detector 
(954D-32; Sigma-Aldrich, Rocklin, CA, USA) was applied 
for 10 minutes and then stained with HRP-compatible 
chromogen for 5 min and counterstained in hematoxylin. 
For negative controls the primary antibody was replaced 
by a diluent.
Images were captured using a DC 300F camera (Leica, 
Wetzlar, Germany) and the image processing and analysis 
software Image Pro Plus v.6.0 (Media Cybernetics, Silver 
Spring, MD, USA). The intensity of immunostaining was 
graded semi-quantitatively on a scale of 0 to ++++, as fol-
lows: 0, no positive structures; 0/+, occasional positive 
structures; +, few immunoreactive structures; ++, a moder-
ate number of immunoreactive structures; +++, numerous 
immunoreactive structures; and ++++, an abundance of 
immunoreactive structures in the visual field10. 
Statistical analysis
Statistical analyses were performed using SPSS v.20.0 
(IBM Corp., Armonk, NY, USA). Results are expressed 
as means ± SD. The Kruskal - Wallis test with Bonferroni 
correction were used to test significant difference between 
groups. The significance level was set at P < 0.05.
RESULTS
CBCLP
MMP-2 and MMP-8-positive structures were detected 
in all CBCLP cases, and the presence of MMP-2, MMP-
8-positive epithelial cells was a few to abundant (Fig. 1, 
2). The number of MMP-2-positive connective tissue 
cells varied from occasional to numerous. Occasional 
MMP-8-positive connective cells were found in CBCLP 
specimens. Moderate numbers of immunoreactive struc-
tures were also observed in the salivary gland cells. In all 
CBCLP specimens, a few to moderate of TIMP-2-positive 
oral mucosa cells were seen. TIMP-2 immunoreactivity 
was detected in epithelial cells, fibroblasts, and macro-
phages. Of note, only a few isolated epithelial and connec-
tive tissue cells stained positively for MMP-9 and TIMP-4 
in CBCLP affected tissue. 
CUCLP
MMP-2-positive structures were present in all soft tis-
sue samples, and immunoreactivity was detected in epi-
thelial cells, fibroblasts, and macrophages. The number of 
MMP-2-positive epithelial cells varied from occasional to 
moderate but positive connective tissue cells were seen in 
a few to numerous positive structures. Furthermore, the 
number of TIMP-2-positive cells varied from occasional 
to numerous in all specimens but the presence of TIMP-
4-positive epithelial cells and connective cells was a few to 
abundant (Fig. 3). It is notable that the immunoreactivity 
for MMP-9 in CUCLP affected tissue was found in all 
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Fig. 1. Moderate MMP-8-positive structures in oral epithelium 
and connective tissue from the cleft lip tissue of a 3-months-old 
child. 100 x magnification.
Fig. 2. Abundant MMP-2-positive epithelial cells from lip tissue 
of 6-moths-old child with CLP. 200 x magnification.
Fig. 3. Abundant TIMP-4-positive cells in basal layer from lip 
tissue of a 3-months-old child with CUCLP. 100 x magnifica-
tion.
Fig. 4. Moderate MMP-9-positive cells in oral epithelium and 
connective tissue  from the lip tissue of a 4-month-old child with 
CUCLP. 200 x magnification.
tissue samples. Occasional to numerous immunoreactive 
cells were observed in epithelium and connective tissue 
(Fig. 4, 5).
In all control specimens, only a few of MMP-2-positive 
epithelial cells were found (Fig. 6). The total number of 
MMP-2-positive cells was significantly lower in the con-
trol than in the CBCLP group (P < 0.016). Notably, of 
the 10 control specimens, 9 were negative for MMP-2 
in the connective tissue. There was significant difference 
between groups in the mean numbers of MMP-2-positive 
connective cells (P < 0.002; P < 0.005). This aside, the 
mean number of TIMP-2-positive connective cells was 
significantly lower in the control group than in the CLP 
groups (P < 0.005; P < 0.002). Further, the total num-
ber of MMP-2-positive cells was significantly lower in 
the CUCLP than in the CBCLP group (P < 0.001). The 
number of MMP-9-positive cells was significantly higher 
in the CUCLP than in the CBCLP group and controls (P 
< 0.001; P < 0.005). The total number of TIMP-4-positive 
cells also showed a significant decrease in the CBCLP and 
controls compared with that of the CUCLP (P < 0.001; 
P < 0.002). MMP-8 expression trends in the CLP groups 
were similar to those of the control group. There was no 
significant difference in mean numbers between groups. 
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DISCUSSION
In humans, morphogenesis of the lip and palate fusion 
is a highly regulated process involving the cooperation of 
different signalling molecules. The upper lip fusion pro-
motes palate formation, and therefore improper lip fusion 
may secondarily affect palate fusion11. MMPs and TIMPs 
have the ability to participate in ECM remodelling during 
lip and palatal fusion and the EMT associated with this 
process. Controlled remodelling of the ECM is an essen-
tial aspect of craniofacial morphogenesis. Experiments in 
mice have suggested MMPs and TIMPs as potential candi-
date genes for CLP, based on expression patterns during 
palate morphogenesis12. If their balance is disrupted, birth 
defects, such as CLP, can occur. Although essential for 
the morphogenesis of craniofacial structures, MMPs and 
TIMPs have not been extensively studied in tissue samples 
obtained from fully developed children with CLP. 
Mouse embryos show distinct temporospatial expres-
sion of MMP-2, MMP-3, MMP-7, MMP-9, MMP-13 and 
TIMP-1, TIMP-2 during palatal fusion. The inactivation 
of MMPs by TIMPs in vitro leads to a failure of fusion 
of mouse palatal shelves13. It has been reported that two 
MMP-mediated pathways are involved in palatal fusion, 
MMP-3 and the MMP-2/a cell membrane-associated 
MMP (MT1-MMP)/TIMP-2 pathway. Furthermore, 
a promoter variant in the TIMP-2 gene was associated 
with NSCLP in Europeans14. TIMP-2 is an inhibitor of 
MMPs and paradoxically it can function as a co-activator 
of pro-MMP-2 as well15. In our study, TIMP-2 positive cell 
distribution varied from a few to moderate positive struc-
tures in the patients examined, and TIMP-2 expression in 
the oral mucosa was lower in the control group than the 
CLP group. Particularly, elevated MMP-2 expression was 
observed in epithelial cells from patients with CBCLP. 
These results suggest the involvement of the MMP-2/MT-
MMP/TIMP-2 pathway in the ECM remodelling directly 
associated with CBCLP.
The role of TIMP-4 local expression in humans CLP 
affected tissue has not been reported.
TIMP-4 may also play a role in activation of proM-
MP-2. Interestingly, Zhang et al. (2003) suggested that 
TIMP-4 may indirectly regulate MMP-2 and MMP-9 gene 
transcription levels16. MMP-9 is known for its activity in 
degrading type IV collagen, the main component of the 
ECM, and facilitates cell migration17. Although Letra et 
al. (2007) provided no evidence of a major role for this 
gene in NSCLP (ref.18), in this study elevated TIMP-4, 
MMP-9 expression was observed in epithelial cells, fi-
broblasts, and macrophages from patients with CUCLP 
and unaffected individuals. In contrast, there were fewer 
TIMP-4, MMP-9-positive cells in tissue samples from pa-
tients with CBCLP. These results show that lower MMP-9 
expression might provide a predominantly scarring signal.
MMP-8 (collagenase-2) of the fibrillar collagenase 
family that also includes MMP-1 and MMP13, is par-
ticularly interesting in the context of CLP affected tissue 
remodelling because it can be expressed by a wide variety 
of cell types including epithelial cells, fibroblasts, endo-
thelial cells, macrophages and neutrophil leukocytes19. 
It has been shown that MMP-8 is present in multiple 
embryonic tissues, including neural crest cells20. Tissues 
of the craniofacial complex are primarily derived from 
neural crest cells. Moreover, MMP-8 is expressed during 
many pathological conditions associated with excessive 
degradation of the ECM, such as periodontitis, osteoar-
thritis, chronic ulcers, and malignant tumours. This study 
shows that MMP-8-positive cell distribution varied from 
occasional to numerous positive structures in the patients. 
The results suggest involvement of MMP-8 locally in the 
breakdown of ECM in CLP affected tissue.
Fig. 5. Sporadic MMP-9 immunoreactivity in oral epithe-
lial cells from the cleft lip tissue of a 4-month-old child with 
CBCLP. 250 x magnification.
Fig. 6. Few MMP-2-positive epithelial cells in oral epithelial 
cells in soft tissue from an unaffected 6-years-old child. 200 x 
magnification.
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CONCLUSIONS 
The results of this study suggest that TIMP-4 and 
MMP-9 are the main ECM remodeling regulatory proteins 
expressed in CUCLP affected tissues of the oral mucosa. 
The increased expression of MMP-2 and TIMP-2 in CLP 
tissues implicates these factors in the regulation of cell mi-
gration during ECM turnover independently of different 
types of clefts. Investigation of MMP and TIMP expres-
sion in tissue samples obtained from patients with CLP 
is a promising approach to the etiopathogenesis of CLP.
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